Does Benign Breast Fibrosis Increase Breast Cancer Risk?

Receiving a breast biopsy result can be highly stressful, and it is completely normal to feel anxious about what it means for your future health.

If your biopsy shows isolated benign breast fibrosis (also called idiopathic stromal fibrosis), current medical evidence does not indicate that this finding causes a clinically meaningful increase in your future risk of developing breast cancer, provided that your care team confirms the biopsy adequately explains your imaging ^[1][2].

By itself, isolated stromal fibrosis is generally considered a non-proliferative, benign (non-cancerous) condition. However, understanding exactly what this diagnosis means requires looking closely at your complete pathology report and your overall breast cancer risk factors.

Fibrosis is Not Precancerous

Fibrosis simply means an overgrowth of connective (fibrous) tissue, similar to a scar. When it occurs without any other cellular abnormalities, it is considered non-proliferative—meaning it does not show the excess growth of breast-lining cells that characterizes some higher-risk lesions. The medical literature generally groups stromal fibrosis with other non-proliferative benign breast changes that do not elevate breast cancer risk on their own ^[3][4].

It is important to review the exact wording of your pathology report, as “fibrosis” is sometimes used alongside other terms that have different implications for your health:

• Atypia (Atypical Hyperplasia): Conditions like atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH) involve abnormal cells (atypia) and excess cell growth (hyperplasia). These conditions do substantially increase the risk of future breast cancer ^[5]. Fibrosis is not atypia.
• Proliferative Lesions without Atypia: Findings like usual ductal hyperplasia, sclerosing adenosis, or a papilloma involve extra cell growth but without abnormal cells. These can slightly elevate risk compared to non-proliferative conditions like isolated fibrosis ^[6].
• Diabetic Mastopathy: This is a specific type of dense fibrous tissue and inflammation found in some people with diabetes, but it also does not turn into cancer ^[7].

The Importance of “Concordance”

Before you can be fully reassured by a diagnosis of benign fibrosis, your radiologist and pathologist must review the results together to confirm radiologic-pathologic concordance ^[8].

Concordance means the benign biopsy results fully explain the abnormality that was originally seen on your mammogram, ultrasound, or MRI. If your imaging showed a highly suspicious mass, but the biopsy only found a small amount of normal fibrous tissue, those results are discordant ^[9]. This can happen if the biopsy needle misses the intended target.

If the results are discordant, a repeat image-guided biopsy or a surgical excision is usually required to ensure no cancer was missed ^[9][10]. You should explicitly ask your doctor if your results have been reviewed and deemed concordant.

What Happens Next: Follow-up and Screening

If your results are benign and concordant, your immediate follow-up and long-term screening plan will be based on your specific situation.

Immediate Follow-up: Depending on your biopsy method and the original imaging finding, your doctor may recommend returning to routine screening, or they may recommend a short-term follow-up imaging test (like a mammogram or ultrasound in 6 to 12 months) just to ensure the area remains stable ^[3].

Future Screening Strategy: Because benign fibrosis itself does not increase your breast cancer risk, your future screening plan should be based on your overall, individualized risk profile ^[11][12]. Your care team will recommend a schedule based on:

• Your age and family history of breast or ovarian cancer ^[13]
• Your genetic testing results (if applicable)
• Your breast density. Dense breasts contain more fibrous and glandular tissue, which makes mammograms harder to read and independently increases breast cancer risk ^[11].
• Any previous biopsies showing high-risk features like atypia ^[5].

Having dense breasts or a history of benign biopsies does not automatically mean you need supplemental screening (tests beyond a standard mammogram, such as an MRI or ultrasound). Supplemental screening can lead to higher false-positive rates and unnecessary biopsies. Breast MRIs are generally reserved for individuals whose combined risk factors give them a calculated lifetime breast cancer risk of 20% or higher ^[12].

When to Contact Your Doctor

A finding of fibrosis does not protect you from developing breast cancer in the future. Regardless of your past benign biopsy, you should always contact your doctor if you notice a new or enlarging lump, skin or nipple retraction, unusual nipple discharge, or any other changes in your breasts.